Advanced search
Publication Cover
Hematology Volume 12, 2007 - Issue 2
Submit an article Journal homepage
362
Views
23
CrossRef citations to date
0
Altmetric
Stem Cell Transplantation

Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation

Kang-er ZhuDepartment of HematologyFirst Affiliated Hospital of Jinan University, Guangzhou510630, People's Republic of China
,
Jun-ping LiDepartment of HematologyFirst Affiliated Hospital of Jinan University, Guangzhou510630, People's Republic of China
,
Tao ZhangDepartment of HematologyFirst Affiliated Hospital of Jinan University, Guangzhou510630, People's Republic of China
,
Juan ZhongDepartment of HematologyFirst Affiliated Hospital of Jinan University, Guangzhou510630, People's Republic of China
&
Jie ChenDepartment of HematologyFirst Affiliated Hospital of Jinan University, Guangzhou510630, People's Republic of China
Pages 117-121 | Published online: 04 Sep 2013

References

  • Gmiir J, Burger J, Schaffmer A, et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990;75:290–295.
  • Lee JH, Lee KH, Kim S, et al. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;25:179–184.
  • Huang XJ, Chen ZX, Wang W. Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation. Chinese J Hematol 2002;26:548–550.
  • Wemet D, Mayer G. Isoagglutins following ABO-incompatible bone marrow transplantation. Vox Sang 1992;62:176–179.
  • Sieff C, Bicknell D, Caine G, et al. Changes in surface antigen express during hemopoietic differentiation. Blood 1982;60: 703–713.
  • Benjamin RJ, Connors JM, McGurk S, et al. Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant 1998A:151–156.
  • Maschan AA, Skorobogatova EV, Balashow DN, et al. Successful treatment of pure red cell aplasia with a single dose of Rituximab in a child after major ABO-incompatible peripheral stem cell transplantation for acquired aplastic anemia. Bone Marrow Transplant 2002;30:405–407.
  • Zhu KB, Chen J, Chen ST. Treatment of Epstein—Barr virus-associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: A case report and literature review. Hematology 2005;10:365–370.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.